SARHIGH SIGNALFINANCIAL10-K

Saratoga Investment Corp experienced a dramatic cash depletion, with cash and equivalents falling from $148.2M to just $1.7M while nearly eliminating share buyback activity.

The severe cash reduction of nearly 99% represents a fundamental shift in the company's liquidity position and financial flexibility. This dramatic change in cash holdings, combined with the virtual elimination of share repurchases, suggests either a major strategic deployment of capital or potential liquidity constraints that warrant close investor scrutiny.

Comparing 2025-05-07 vs 2024-05-06View on EDGAR →
FINANCIAL ANALYSIS

The company's financial profile shows a mixed picture with net income growing modestly to $36.6M and dividend payments increasing to $52.4M, demonstrating continued profitability and shareholder returns. However, the most striking change is the dramatic depletion of cash reserves to just $1.7M from $148.2M, while share buyback activity was virtually eliminated. This severe reduction in liquid assets represents a fundamental shift in the company's balance sheet that overshadows the positive earnings performance.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
-98.9%
$148.2M$1.7M

Cash declined 98.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Share Buybacks
Cash Flow
-97.5%
$2.2M$54K

Buyback activity reduced 97.5% — capital being redeployed elsewhere or cash conservation underway.

Net Income
P&L
+30.3%
$28.1M$36.6M

Net income grew 30.3% — bottom-line growth signals improving overall business health.

Dividends Paid
Cash Flow
+28.5%
$40.7M$52.4M

Dividend payments increased 28.5% — management confidence in sustained cash generation.

LANGUAGE CHANGES
NEW — 2025-05-07
PRIOR — 2024-05-06
ADDED
The number of outstanding common shares of the registrant as of May 6, 2025 was 15,364,864 .
As of February 28, 2025, we had total assets of $1,191.5 million and investments in 48 portfolio companies, excluding an investment in the subordinated notes of one collateralized loan obligation fund, Saratoga Investment Corp.
( Saratoga CLO ), which had a fair value of $0.2 million as of February 28, 2025, investment in the Class F-2-R-3 Note of Saratoga CLO which as of February 28, 2025 had a fair value of $2.3 million, investment in the Class E Note of Saratoga Investment Corp.
Senior Loan Fund 2022-1, Ltd which as of February 28, 2025 has affair value of $12.3 million and investments in the Saratoga Senior Loan Fund I JV LLC ( SLF JV ) and its subsidiaries, a joint venture which as of February 28, 2025 had a fair value of $19.6 million.
The overall portfolio composition as of February 28, 2025 consisted of 88.7% of first lien term loans, 0.7% of second lien term loans, 1.7% of unsecured loans, 1.5% of structured finance securities and 7.4% of equity interests.
+7 more — sign up free →
REMOVED
The number of outstanding com mon shares of the registrant as of May 3, 2024 was 13,698,966 .
As of February 29, 2024, we had total assets of $1,191.2 million and investments in 55 portfolio companies, excluding an investment in the subordinated notes of one collateralized loan obligation fund, Saratoga Investment Corp.
( Saratoga CLO ), which had a fair value of $9.5 million as of February 29, 2024, investments in the Class F-2-R-3 Note of the Saratoga CLO which as of February 29, 2024 had a fair value of $8.9 million, and investments in the Saratoga Senior Loan Fund I JV LLC ( SLF JV ) and its subsidiaries, a joint venture which as of February 29, 2024 had a fair value of $25.2 million.
The overall portfolio composition as of February 29, 2024 consisted of 85.7% of first lien term loans, 1.6% of second lien term loans, 1.4% of unsecured loans, 2.7% of structured finance securities and 8.6% of equity interests.
As of February 29, 2024, the weighted average yield on all of our investments, including our investment in the subordinated notes of Saratoga CLO and Class F-2-R-3 Note was approximately 11.4%.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →